Christian Reinhard Mayr

Christian Reinhard Mayr is an Associate Professor and Privatdozent at the University of Salzburg, affiliated with the University Institute of Physiology and Pathophysiology and the Salzburg University Clinic for Internal Medicine 1. His research focuses on molecular mechanisms of biliary tract cancers, ferroptosis modulation, and drug development for gastrointestinal malignancies. He holds dual Master's degrees in Genetics and TREAT (Translational Research), and a Doctorate in Natural Sciences (Dr.rer.nat.).

Education:

• Doctorate in Genetics, University of Salzburg (2015)
• Master's in Genetics, University of Salzburg (2012)
• Additional MSc in TREAT (Translational Research)

Research interests include:

• Ferroptosis as therapeutic target in chondrocytes and cancer cells
• Development of drug conjugates for biliary tract cancers
• Preclinical models for cholangiocarcinoma drug screening
• Epigenetic therapy resistance mechanisms in lymphomas
• Biomarker discovery using multi-omics approaches

His publications highlight contributions to cannabinoid-based ferroptosis modulation, drug conjugate pharmacology, and HDAC inhibitor mechanisms. Recent projects include investigating EZH1 as a therapeutic target and evaluating ouabain's anticancer potential.

He has supervised multiple theses including studies on novel biliary tract cancer therapies, cardiovascular effects of aspirin, and psychocardiology. Active in teaching, he contributes to human medicine courses on respiratory systems and ECG analysis.

Notable awards include the Christian Doppler Prize (2019) and scholarships from the Salzburg Science Foundation during his doctoral and master's studies.